Silk Road Medical Inc (SILK) concluded trading on Tuesday at a closing price of $26.88, with 24.66 million shares of worth about $662.75 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 162.50% during that period and on June 18, 2024 the price saw a gain of about 24.04%. Currently the company’s common shares owned by public are about 39.17M shares, out of which, 35.84M shares are available for trading.
Stock saw a price change of 21.35% in past 5 days and over the past one month there was a price change of 21.19%. Year-to-date (YTD), SILK shares are showing a performance of 119.07% which decreased to -15.89% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.08 but also hit the highest price of $34.13 during that period. The average intraday trading volume for Silk Road Medical Inc shares is 586.04K. The stock is currently trading 24.36% above its 20-day simple moving average (SMA20), while that difference is up 33.39% for SMA50 and it goes to 78.40% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Silk Road Medical Inc (NASDAQ: SILK) currently have 39.17M outstanding shares and institutions hold larger chunk of about 103.73% of that.
The stock has a current market capitalization of $1.06B and its 3Y-monthly beta is at 1.49. It has posted earnings per share of -$1.37 in the same period. It has Quick Ratio of 9.62 while making debt-to-equity ratio of 0.57. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SILK, volatility over the week remained 4.31% while standing at 4.71% over the month.
Stock’s fiscal year EPS is expected to rise by 4.78% while it is estimated to increase by 5.75% in next year. EPS is likely to grow at an annualized rate of 16.20% for next 5-years, compared to annual growth of -3.21% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Argus on March 07, 2024 offering a Buy rating for the stock and assigned a target price of $24 to it. Coverage by Stifel stated Silk Road Medical Inc (SILK) stock as a Buy in their note to investors on January 19, 2024, suggesting a price target of $20 for the stock. Stock get a Hold rating from Stifel on October 11, 2023.
